Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia

Journal of Applied Physiology

Volumn 114, Issue 7, 2013, Pages 879-887

  Huxtable, A G ^a   Smith, S M C ^a   Vinit, S ^a   Watters, J J ^a   Mitchell, G S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Inflammation; Inflammatory genes; Microglia; Plasticity; Respiratory motor neuron; Spinal cord

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE;

ACUTE DISEASE; ANIMAL; ANOXIA; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; LONG TERM POTENTIATION; MALE; MYELITIS; PHRENIC NERVE; RAT; SPRAGUE DAWLEY RAT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACUTE DISEASE; ANIMALS; ANOXIA; CYTOKINES; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; LONG-TERM POTENTIATION; MALE; MYELITIS; PHRENIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84878524918     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01347.2012     Document Type: Article

References (73)

1. Amor S, Puentes F, Baker D, Van der Valk P. Inflammation in neurodegenerative diseases. Immunology 129:154-169, 2010.
2. Bach KB, Mitchell GS. Hypoxia-induced long-term facilitation of respiratory activity is serotonin dependent. Respir Physiol 104:251-260, 1996. (Pubitemid 26302799)
3. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, Mitchell GS. BDNF necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 7:48-55, 2004. (Pubitemid 38032167)
4. Baker-Herman TL, Mitchell GS. Determinants of frequency long-term facilitation following acute intermittent hypoxia in vagotomized rats. Respir Physiol Neurobiol 162:8-17, 2008. (Pubitemid 351794578)
5. Baker-Herman TL, Mitchell GS. Phrenic long-term facilitation requires spinal serotonin receptor activation and protein synthesis. J Neurosci 22:6239-6246, 2002. (Pubitemid 35387664)
6. Balan KV, Kc P, Hoxha Z, Mayer CA, Wilson CG, Martin RJ. Vagal afferents modulate cytokine-mediated respiratory control at the neonatal medulla oblongata. Respir Physiol Neurobiol 178:458-464, 2011.
7. Bhattacharjee R, Kim J, Kheirandish-Gozal L, Gozal D. Obesity and obstructive sleep apnea syndrome in children: A tale of inflammatory cascades. Pediatr Pulmonol 46:313-323, 2010.
8. Blatteis CM. The onset of fever: new insights into its mechanism. Prog Brain Res 162:3-14, 2007. (Pubitemid 47080944)
9. Blatteis CM, Li S. Pyrogenic signaling via vagal afferents: what stimulates their receptors? Auton Neurosci 85:66-71, 2000.
10. Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 13:2487-2502, 2006. (Pubitemid 44364151)
11. Buritova J, Honore P, Besson JM. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain 67:379-389, 1996. (Pubitemid 26375355)
12. Cabre F, Fernandez MF, Calvo L, Ferrer X, Garcia ML, Mauleon D. Analgesic, antiinflammatory, and antipyretic effects of S (+)-ketoprofen vivo. J Clin Pharmacol 38:3S-10S, 1998. (Pubitemid 29047343)
13. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 5:13-23, 1996. (Pubitemid 26379062)
14. Conrad A, Bull DF, King MG, Husband AJ. The effects of lipopolysaccharide (LPS) on the fever response in rats at different ambient temperatures. Physiol Behav 62:1197-1201, 1997. (Pubitemid 27490416)
15. Crain JM, Nikodemova M, Watters JJ. Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia. J Neuroinflammation 6:24, 2009.
16. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, Rawlins JN, Perry VH. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65:304-312, 2009.
17. Deakin AM, Payne AN, Whittle BJ, Moncada S. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 7:408-416, 1995.
18. Di Filippo M, Sarchielli P, Picconi B, Calabresi P. Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29:402-412, 2008.
19. Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci 26:239-266, 2003. (Pubitemid 37064934)
20. Fuller DD, Bach KB, Baker TL, Kinkead R, Mitchell GS. Long term facilitation of phrenic motor output. Respir Physiol 121:135-146, 2000. (Pubitemid 30645513)
21. Ge X, Yang Z, Duan L, Rao Z. Evidence for involvement of the neural pathway containing the peripheral vagus nerve, medullary visceral zone and central amygdaloid nucleus in neuroimmunomodulation. Brain Res 914:149-158, 2001. (Pubitemid 32905441)
22. Godbout JP, Berg BM, Kelley KW, Johnson RW. alpha-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol 149:101-109, 2004. (Pubitemid 38352863)
23. Goehler LE, Gaykema RPA, Nguyen KT, Lee JE, Tilders FJH, Maier SF, Watkins LR. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci 19:2799-2806, 1999. (Pubitemid 29162426)
24. Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med 1:S12-S16, 2009.
25. Graeber MB. Changing face of microglia. Science 330:783-788, 2010.
26. Hashimoto M, Nitta A, Fukumitsu H, Nomoto H, Shen L, Furukawa S. Inflammation-induced GDNF improves locomotor function after spinal cord injury. Neuroreport 16:99-102, 2005. (Pubitemid 40250377)
27. Hoffman MS, Nichols NL, Macfarlane PM, Mitchell GS. Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis. J Appl Physiol 113:1184-1193, 2012.
28. Holden JM, Meyers-Manor JE, Overmier JB, Gahtan E, Sweeney W, Miller H. Lipopolysaccharide-induced immune activation impairs attention but has little effect on short-term working memory. Behav Brain Res 194:138-145, 2008.
29. Huxtable AG, Vinit S, Windelborn JA, Crader SM, Guenther CH, Watters JJ, Mitchell GS. Systemic inflammation impairs respiratory chemoreflexes and plasticity. Respir Physiol Neurobiol 178:482-489, 2011.
30. Kaminska B, Gozdz A, Zawadzka M, Ellert-Miklaszewska A, Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec (Hoboken) 292:1902-1913, 2009.
31. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF. Cyclooxygenases and the central nervous system. Prostaglandins 54:601-624, 1997. (Pubitemid 27495921)
32. Kelly A, Laroche S, Davis S. Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsolidation of recognition memory. J Neurosci 23:5354-5360, 2003. (Pubitemid 36793264)
33. Kimoff RJ, Hamid Q, Divangahi M, Hussain S, Bao W, Naor N, Payne RJ, Ariyarajah A, Mulrain K, Petrof BJ. Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea. Eur Respir J 38:89-97, 2010.
34. Kozak W, Soszynski D, Rudolph K, Conn CA, Kluger MJ. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. Am J Physiol Regul Integr Comp Physiol 272:R1298-R1307, 1997.
35. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318, 1996. (Pubitemid 26349059)
36. Laflamme N, Lacroix S, Rivest S. An essential role of interleukin-1beta in mediating NF-kappa B activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 19:10923-10930, 1999. (Pubitemid 30235736)
37. Leon CG, Tory R, Jia J, Sivak O, Wasan KM. Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 25:1751-1761, 2008.
38. MacFarlane PM, Mitchell GS. Episodic spinal serotonin receptor activation elicits long-lasting phrenic motor facilitation by an NADPH oxidasedependent mechanism. J Physiol 587:5469-5481, 2009.
39. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann NY Acad Sci 840:289-300, 1998. (Pubitemid 28302056)
40. McColl BW, Allan SM, Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158:1049-1061, 2009.
41. Mitchell GS, Johnson SM. Neuroplasticity in respiratory motor control. J Appl Physiol 94:358-374, 2003.
42. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6:945-951, 2006.
43. Nikodemova M, Watters JJ. Efficient isolation of live microglia with preserved phenotypes from adult mouse brain. J Neuroinflammation 9:147, 2012.
44. Ossipov MH, Jerussi TP, Ren K, Sun H, Porreca F. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain 87:193-199, 2000. (Pubitemid 30621451)
45. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990. (Pubitemid 20242299)
46. Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol (Berl) 120:277-286, 2010.
47. Pinardi G, Sierralta F, Miranda HF. Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice. Pharmacol Biochem Behav 74:603-608, 2003. (Pubitemid 36126538)
48. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085-2088, 1998. (Pubitemid 29001265)
49. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453-462, 2007. (Pubitemid 46383175)
50. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor-alpha from macrophages: Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 141:2388-2393, 1988.
51. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84:731-765, 2004. (Pubitemid 38823765)
52. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26:761-788, 2001. (Pubitemid 32918282)
53. Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol 9:429-439, 2009.
54. Roth J, De Souza GE. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 34:301-314, 2001. (Pubitemid 33605793)
55. Schnydrig S, Korner L, Landweer S, Ernst B, Walker G, Otten U, Kunz D. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett 429:69-73, 2007. (Pubitemid 350116355)
56. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, Ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88:7438-7442, 1991. (Pubitemid 21915167)
57. Shaw KN, Commins S, O'Mara SM. Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res 124:47-54, 2001. (Pubitemid 32567558)
58. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201:197-207, 2004. (Pubitemid 39023946)
59. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci 26:10709-10716, 2006.
60. Stockley RA. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 25:1235-1245, 2009.
61. Swiergiel AH, Dunn AJ. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 86:651-659, 2007. (Pubitemid 46829318)
62. Teeling JL, Felton LM, Deacon RM, Cunningham C, Rawlins JN, Perry VH. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun 21:836-850, 2007. (Pubitemid 47002211)
63. Teeling JL, Perry VH. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158:1062-1073, 2009.
64. Thomson LM, Sutherland RJ. Systemic administration of lipopolysaccharide and interleukin-1beta have different effects on memory consolidation. Brain Res Bull 67:24-29, 2005. (Pubitemid 41225314)
65. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235, 1971.
66. Vereker E, Campbell V, Roche E, McEntee E, Lynch MA. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 275:26, 252-26, 258, 2000.
67. Vinit S, Windelborn JA, Mitchell GS. Lipopolysaccharide attenuates phrenic long-term facilitation following acute intermittent hypoxia. Respir Physiol Neurobiol 176:130-135, 2011.
68. Walker JS. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol 22:855-860, 1995.
69. Wieczorek M, Swiergiel AH, Pournajafi-Nazarloo H, Dunn AJ. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol Behav 85:500-511, 2005. (Pubitemid 41020765)
70. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17:255-281, 1999. (Pubitemid 29241125)
71. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci USA 94:227-232, 1997. (Pubitemid 27027191)
72. Yamawaki Y, Kimura H, Hosoi T, Ozawa K. MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus. Am J Physiol Regul Integr Comp Physiol 298:R403-R410, 2010.
73. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I (kappa) B kinase-beta. Nature 396:77-80, 1998. (Pubitemid 28520452)